TY - JOUR
T1 - Three-dimensional intracardiac echocardiography for left atrial appendage sizing and percutaneous occlusion guidance
AU - Della Rocca, Domenico G
AU - Magnocavallo, Michele
AU - Gianni, Carola
AU - Mohanty, Sanghamitra
AU - Al-Ahmad, Amin
AU - Bassiouny, Mohamed
AU - Denora, Marialessia
AU - La Fazia, Vincenzo Mirco
AU - Lavalle, Carlo
AU - Gallinghouse, Gerald J
AU - Santangeli, Pasquale
AU - Polselli, Marco
AU - Sarkozy, Andrea
AU - Vetta, Giampaolo
AU - Ahmed, Adnan
AU - Sanchez, Javier E
AU - Pannone, Luigi
AU - Chierchia, Gian-Battista
AU - Tschopp, David R
AU - De Asmundis, Carlo
AU - Di Biase, Luigi
AU - Lakkireddy, Dhanunjaya
AU - Burkhardt, David J
AU - Horton, Rodney P
AU - Natale, Andrea
N1 - Publisher Copyright:
© 2024 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - Aims: Left atrial appendage (LAA) imaging is critical during percutaneous occlusion procedures. 3D-intracardiac echocardiography (ICE) features direct visualization of LAA from multiple cross-sectional planes at a time. We aimed at reporting procedural success of 3D-ICE-guided LAA occlusion and the correlation between pre-procedural transoesophageal echocardiography (TEE) and intraprocedural 3D-ICE for LAA sizing. Methods and results: Among 274 patients undergoing left atrial appendage occlusion (LAAO) with a Watchman FLX, periprocedural ICE guidance was achieved via a commercially available 2D-ICE catheter (220 patients) or a novel (NUVISION™) 3D-ICE one (54 patients). Primary endpoint was a composite of procedural success and LAA sealing at follow-up TEE. Secondary endpoint was a composite of periprocedural device recapture/resizing plus presence of leaks ≥ 3amm at follow-up TEE. 3D-ICE measurements of maximum landing zone correlated highly with pre-procedural TEE reference values [Pearson's: 0.94; P < 0.001; bias:-0.06 (-2.39, 2.27)]. The agreement between 3D-ICE-based device selection and final device size was 96.3% vs. 79.1% with 2D-ICE (P = 0.005). The incidence of the primary endpoint was 98.1% with 3D-ICE and 97.3% with 2D-ICE (P = 0.99). 2D-ICE patients had a trend towards a higher incidence of periprocedural device recapture/redeployment (31.5% vs. 44.5%; P = 0.09). The secondary endpoint occurred in 31.5% of 3D-ICE patients vs. 45.9% of 2D-ICE ones (P = 0.065). Conclusion: Intracardiac echocardiography-guided LAAO showed a very high success, with no major adverse events. A very high level of agreement for LAA sizing was found between pre-procedural TEE and periprocedural 3D-ICE. 3D-ICE performed significantly better than 2D-ICE for FLX size selection and may provide better guidance during device deployment.
AB - Aims: Left atrial appendage (LAA) imaging is critical during percutaneous occlusion procedures. 3D-intracardiac echocardiography (ICE) features direct visualization of LAA from multiple cross-sectional planes at a time. We aimed at reporting procedural success of 3D-ICE-guided LAA occlusion and the correlation between pre-procedural transoesophageal echocardiography (TEE) and intraprocedural 3D-ICE for LAA sizing. Methods and results: Among 274 patients undergoing left atrial appendage occlusion (LAAO) with a Watchman FLX, periprocedural ICE guidance was achieved via a commercially available 2D-ICE catheter (220 patients) or a novel (NUVISION™) 3D-ICE one (54 patients). Primary endpoint was a composite of procedural success and LAA sealing at follow-up TEE. Secondary endpoint was a composite of periprocedural device recapture/resizing plus presence of leaks ≥ 3amm at follow-up TEE. 3D-ICE measurements of maximum landing zone correlated highly with pre-procedural TEE reference values [Pearson's: 0.94; P < 0.001; bias:-0.06 (-2.39, 2.27)]. The agreement between 3D-ICE-based device selection and final device size was 96.3% vs. 79.1% with 2D-ICE (P = 0.005). The incidence of the primary endpoint was 98.1% with 3D-ICE and 97.3% with 2D-ICE (P = 0.99). 2D-ICE patients had a trend towards a higher incidence of periprocedural device recapture/redeployment (31.5% vs. 44.5%; P = 0.09). The secondary endpoint occurred in 31.5% of 3D-ICE patients vs. 45.9% of 2D-ICE ones (P = 0.065). Conclusion: Intracardiac echocardiography-guided LAAO showed a very high success, with no major adverse events. A very high level of agreement for LAA sizing was found between pre-procedural TEE and periprocedural 3D-ICE. 3D-ICE performed significantly better than 2D-ICE for FLX size selection and may provide better guidance during device deployment.
KW - FLX
KW - Intracardiac echocardiography
KW - Left atrial appendage
KW - Stroke
KW - Thromboembolism
KW - Transoesophageal echocardiography
KW - Watchman
KW - article
KW - cerebrovascular accident
KW - cohort analysis
KW - complication
KW - controlled study
KW - female
KW - follow up
KW - heart atrium appendage
KW - human
KW - incidence
KW - intracardiac echocardiography
KW - left atrial appendage closure
KW - left atrial appendage closure device
KW - major clinical study
KW - male
KW - reference value
KW - thromboembolism
KW - transesophageal echocardiography
UR - http://www.scopus.com/inward/record.url?scp=85184015486&partnerID=8YFLogxK
U2 - 10.1093/europace/euae010
DO - 10.1093/europace/euae010
M3 - Article
VL - 26
JO - Europace
JF - Europace
SN - 1099-5129
IS - 1
M1 - euae010
ER -